These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 34060079)

  • 41. Genomic Surveillance of Circulating SARS-CoV-2 in South East Italy: A One-Year Retrospective Genetic Study.
    Capozzi L; Bianco A; Del Sambro L; Simone D; Lippolis A; Notarnicola M; Pesole G; Pace L; Galante D; Parisi A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33922257
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The first SARS-CoV-2 genetic variants of concern (VOC) in Poland: The concept of a comprehensive approach to monitoring and surveillance of emerging variants.
    Charkiewicz R; Nikliński J; Biecek P; Kiśluk J; Pancewicz S; Moniuszko-Malinowska AM; Flisiak R; Krętowski AJ; Dzięcioł J; Moniuszko M; Gierczyński R; Juszczyk G; Reszeć J
    Adv Med Sci; 2021 Sep; 66(2):237-245. PubMed ID: 33827042
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Postvaccination SARS-COV-2 among Health Care Workers in New Jersey: A Genomic Epidemiological Study.
    Mathema B; Chen L; Chow KF; Zhao Y; Zody MC; Mediavilla JR; Cunningham MH; Composto K; Lee A; Oschwald DM; Germer S; Fennessey S; Patel K; Wilson D; Cassell A; Pascual L; Ip A; Corvelo A; Dar S; Kramer Y; Maniatis T; Perlin DS; Kreiswirth BN
    Microbiol Spectr; 2021 Dec; 9(3):e0188221. PubMed ID: 34787439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Continued improvement in the development of the SARS-CoV-2 whole genome sequencing proficiency testing program.
    Lau KA; Foster CSP; Theis T; Draper J; Sullivan MJ; Ballard S; Rawlinson WD
    Pathology; 2024 Aug; 56(5):717-725. PubMed ID: 38729860
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Precision Response to the Rise of the SARS-CoV-2 B.1.1.7 Variant of Concern by Combining Novel PCR Assays and Genome Sequencing for Rapid Variant Detection and Surveillance.
    Zelyas N; Pabbaraju K; Croxen MA; Lynch T; Buss E; Murphy SA; Shokoples S; Wong A; Kanji JN; Tipples G
    Microbiol Spectr; 2021 Sep; 9(1):e0031521. PubMed ID: 34378966
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prolonged SARS-CoV-2 positivity: a challenge for Australian clinicians.
    Milliken EJT; Browning S; Rohl DA
    Med J Aust; 2021 Jan; 214(1):45-45.e1. PubMed ID: 33314137
    [No Abstract]   [Full Text] [Related]  

  • 47. Mass testing for covid-19 in the UK.
    Gill M; Gray M
    BMJ; 2020 Nov; 371():m4436. PubMed ID: 33199289
    [No Abstract]   [Full Text] [Related]  

  • 48. Advancements in detection of SARS-CoV-2 infection for confronting COVID-19 pandemics.
    Zhou Y; Zhang L; Xie YH; Wu J
    Lab Invest; 2022 Jan; 102(1):4-13. PubMed ID: 34497366
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pandemic whistle-blower: we need a non-political way to track viruses.
    Maxmen A
    Nature; 2021 Apr; 592(7852):21. PubMed ID: 33742176
    [No Abstract]   [Full Text] [Related]  

  • 50. Insights into SARS-CoV-2 Surveillance among Prison Populations in Mato Grosso do Sul, Brazil, in 2022.
    Ferreira da Silva L; Alcantara LCJ; Fonseca V; Frias D; Umaki Zardin MCS; de Castro Lichs GG; Esposito AOP; Xavier J; Fritsch H; Lima M; de Oliveira C; Castilho de Arruda LD; Maziero LMA; Rodrigues Barretos EC; Tsuha Oshiro PE; Gimenes Mendes Menezes EF; de Freitas Cardoso L; Ferreira Lemos E; Lourenço J; de Albuquerque CFC; do Carmo Said RF; Rosewell A; Ferraz Demarchi LH; Croda J; Giovanetti M; Maymone Gonçalves CC
    Viruses; 2024 Jul; 16(7):. PubMed ID: 39066305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Test, trace, and isolate in the UK.
    Cheng HY; Cohen T; Lin HH
    BMJ; 2021 Mar; 372():n822. PubMed ID: 33789886
    [No Abstract]   [Full Text] [Related]  

  • 52. SARS-CoV-2 genomics as a springboard for future disease mitigation in LMICs.
    Belman S; Saha S; Beale MA
    Nat Rev Microbiol; 2022 Jan; 20(1):3. PubMed ID: 34799703
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Different Strategies for the Identification of SARS-CoV-2 Variants in the Laboratory Practice.
    Anaclerio F; Ferrante R; Mandatori D; Antonucci I; Capanna M; Damiani V; Tomo PD; Ferrante R; Ranaudo M; De Laurenzi V; Stuppia L; De Fabritiis S
    Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2.
    van Dorp L; Richard D; Tan CCS; Shaw LP; Acman M; Balloux F
    Nat Commun; 2020 Nov; 11(1):5986. PubMed ID: 33239633
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variants of concern responsible for SARS-CoV-2 vaccine breakthrough infections from India.
    Singh UB; Rophina M; Chaudhry R; Senthivel V; Bala K; Bhoyar RC; Jolly B; Jamshed N; Imran M; Gupta R; Aggarwal P; Divakar MK; Sinha S; Arvinden VR; Bajaj A; Shamnath A; Jain A; ; Scaria V; Sivasubbu S; Guleria R
    J Med Virol; 2022 Apr; 94(4):1696-1700. PubMed ID: 34786733
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genomic characterization of SARS-CoV-2 isolates from patients in Turkey reveals the presence of novel mutations in spike and nsp12 proteins.
    Sahin E; Bozdayi G; Yigit S; Muftah H; Dizbay M; Tunccan OG; Fidan I; Caglar K
    J Med Virol; 2021 Oct; 93(10):6016-6026. PubMed ID: 34241906
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genome Sequencing of Sewage Detects Regionally Prevalent SARS-CoV-2 Variants.
    Crits-Christoph A; Kantor RS; Olm MR; Whitney ON; Al-Shayeb B; Lou YC; Flamholz A; Kennedy LC; Greenwald H; Hinkle A; Hetzel J; Spitzer S; Koble J; Tan A; Hyde F; Schroth G; Kuersten S; Banfield JF; Nelson KL
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468686
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel SARS-CoV-2 Variants in Italy: The Role of Veterinary Public Health Institutes.
    Lorusso A; Calistri P; Savini G; Morelli D; Ambrosij L; Migliorati G; D'Alterio N
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33806104
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Translational control of coronaviruses.
    de Breyne S; Vindry C; Guillin O; Condé L; Mure F; Gruffat H; Chavatte L; Ohlmann T
    Nucleic Acids Res; 2020 Dec; 48(22):12502-12522. PubMed ID: 33264393
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rapid deployment of pathology services to a remote Australian quarantine setting during the COVID-19 pandemic.
    Branley J; O'Sullivan M; Polkinghorne A; Poljak M; Stephens D
    Pathology; 2020 Dec; 52(7):821-823. PubMed ID: 32798071
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.